Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $136,553 | 36 | 60.9% |
| Consulting Fee | $52,324 | 17 | 23.3% |
| Travel and Lodging | $19,211 | 67 | 8.6% |
| Food and Beverage | $7,212 | 92 | 3.2% |
| Unspecified | $6,081 | 2 | 2.7% |
| Honoraria | $2,703 | 1 | 1.2% |
| Education | $129.45 | 2 | 0.1% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $95,545 | 77 | $0 (2024) |
| Genentech USA, Inc. | $51,533 | 42 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $31,169 | 26 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $23,681 | 36 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $17,678 | 21 | $0 (2024) |
| Blueprint Medicines Corporation | $3,187 | 4 | $0 (2023) |
| F. Hoffmann-La Roche AG | $659.38 | 1 | $0 (2024) |
| Shire North American Group Inc | $120.36 | 1 | $0 (2017) |
| Phadia US Inc. | $117.32 | 1 | $0 (2019) |
| Optinose US, Inc. | $115.63 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $50,785 | 36 | Novartis Pharmaceuticals Corporation ($25,758) |
| 2023 | $58,600 | 71 | GENZYME CORPORATION ($41,128) |
| 2022 | $33,170 | 29 | GENZYME CORPORATION ($18,867) |
| 2021 | $35,458 | 34 | GENZYME CORPORATION ($20,875) |
| 2020 | $76.12 | 1 | ALK-Abello, Inc ($76.12) |
| 2019 | $347.51 | 3 | AstraZeneca Pharmaceuticals LP ($230.19) |
| 2018 | $24,034 | 20 | Genentech USA, Inc. ($17,043) |
| 2017 | $21,744 | 23 | Genentech USA, Inc. ($21,530) |
All Payment Transactions
217 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $4,550.00 | General |
| 12/13/2024 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $262.20 | General |
| 12/13/2024 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | Cash or cash equivalent | $239.86 | General |
| 12/13/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $171.46 | General |
| 12/13/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $75.00 | General |
| 12/13/2024 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $45.00 | General |
| 12/13/2024 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $11.00 | General |
| 11/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,942.00 | General |
| Category: Immunology | ||||||
| 11/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $100.10 | General |
| Category: Immunology | ||||||
| 11/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | Cash or cash equivalent | $91.12 | General |
| Category: Immunology | ||||||
| 11/13/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | Cash or cash equivalent | $3.50 | General |
| Category: Immunology | ||||||
| 10/25/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $55.53 | General |
| 09/30/2024 | F. Hoffmann-La Roche AG | Xolair (Biological) | — | In-kind items and services | $659.38 | Research |
| Study: Improving The Quality Of Care For Patients With CSU: Study Design And Patient Baseline Characteristics • Category: Immunology | ||||||
| 08/22/2024 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $1,350.00 | General |
| 08/12/2024 | Novartis Pharmaceuticals Corporation | — | — | Cash or cash equivalent | $5,421.25 | Research |
| Study: Research Publication/ Writing Support | ||||||
| 07/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: Immunology | ||||||
| 07/13/2024 | Novartis Pharmaceuticals Corporation | — | Consulting Fee | Cash or cash equivalent | $4,881.25 | General |
| 07/13/2024 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $197.22 | General |
| 07/13/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $130.68 | General |
| 07/13/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $118.09 | General |
| 07/13/2024 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $79.40 | General |
| 07/13/2024 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | Cash or cash equivalent | $30.82 | General |
| 07/12/2024 | Novartis Pharmaceuticals Corporation | — | Travel and Lodging | In-kind items and services | $399.38 | General |
| 05/21/2024 | Regeneron Healthcare Solutions, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $7,340.00 | General |
| 05/21/2024 | Regeneron Healthcare Solutions, Inc. | — | Travel and Lodging | In-kind items and services | $554.97 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Research Publication/ Writing Support | Novartis Pharmaceuticals Corporation | $5,421 | 1 |
| Improving The Quality Of Care For Patients With CSU: Study Design And Patient Baseline Characteristics | F. Hoffmann-La Roche AG | $659.38 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 70 | 84 | $39,587 | $6,173 |
| 2022 | 2 | 23 | 35 | $16,382 | $2,615 |
| 2021 | 1 | 13 | 19 | $6,997 | $1,357 |
| 2020 | 1 | 13 | 20 | $7,160 | $1,120 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 26 | 38 | $15,862 | $2,648 | 16.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $18,324 | $2,562 | 14.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 20 | $5,401 | $963.11 | 17.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 24 | $9,056 | $1,754 | 19.4% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 11 | 11 | $7,326 | $860.47 | 11.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 13 | 19 | $6,997 | $1,357 | 19.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 13 | 20 | $7,160 | $1,120 | 15.6% |
About Dr. David Lang, MD
Dr. David Lang, MD is a Allergy & Immunology healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396709747.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Lang, MD has received a total of $224,213 in payments from pharmaceutical and medical device companies, with $50,785 received in 2024. These payments were reported across 217 transactions from 17 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($136,553).
As a Medicare-enrolled provider, Lang has provided services to 119 Medicare beneficiaries, totaling 158 services with total Medicare billing of $11,265. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Allergy & Immunology
- Location Cleveland, OH
- Active Since 04/13/2006
- Last Updated 03/13/2008
- Taxonomy Code 207K00000X
- Entity Type Individual
- NPI Number 1396709747
Products in Payments
- DUPIXENT (Biological) $24,465
- Xolair (Biological) $17,518
- FASENRA (Drug) $7,047
- FASENRA (Biological) $6,589
- AYVAKIT (Drug) $3,187
- AIRSUPRA (Drug) $2,864
- TEZSPIRE (Biological) $296.61
- CINRYZE (Drug) $120.36
- ImmunoCAP (Device) $117.32
- Xhance (Drug) $115.63
- Orladeyo (Drug) $81.82
- NUCALA (Biological) $76.96
- Odactra (Drug) $76.12
- NIOX VERO DEVICE (Device) $58.05
- EUCRISA (Drug) $34.95
- GENERAL - BRONCHIAL THERMOPLASTY (Device) $16.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Allergy & Immunology Doctors in Cleveland
James Fernandez, Md, MD
Allergy & Immunology — Payments: $242,503
Dr. Joao Pedro Matias Lopes, M.d, M.D
Allergy & Immunology — Payments: $59,456
Mark Aronica, M.d, M.D
Allergy & Immunology — Payments: $7,202
Anushka Khaira, Do, DO
Allergy & Immunology — Payments: $2,853
Sara Ghannam, M.d, M.D
Allergy & Immunology — Payments: $1,753
Dr. Bridget Wilson, Md, MD
Allergy & Immunology — Payments: $855.27